Zhejiang Hisun Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is DACTINOMYCIN USP, with a corresponding US DMF Number 20658.
Remarkably, this DMF maintains an Active status since its submission on June 20, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 09, 2013, and payment made on December 18, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II